AIM
GMED icon

AXA Investment Managers’s Globus Medical GMED Stock Holding History

AXA Investment Managers’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$68.9M Buy
+1,202,828
New +$69.3M 0.19% 109

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

AXA Investment Managers's GMED Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Globus Medical (GMED) in Q3 2025: 1,202,828 shares worth $68.9M. The stake represents 0.19% of the portfolio and ranks #109 among its holdings.

490 funds tracked by Wall St. Rank hold GMED as of Q3 2025.

  • AXA Investment Managers held 1,202,828 shares of Globus Medical worth $68.9M as of Q3 2025.
  • Globus Medical was a new AXA Investment Managers position in Q3 2025.
  • Globus Medical made up 0.19% of AXA Investment Managers's portfolio in Q3 2025, its #109 holding.
  • 490 funds tracked by Wall St. Rank held Globus Medical as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.